Novo Nordisk A/S (NYSE:NVO) Given Overweight Rating at Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a report released on Monday, Benzinga reports. Cantor Fitzgerald currently has a $160.00 price target on the stock. Several other brokerages have also commented on NVO. StockNews.com lowered Novo Nordisk A/S from a strong-buy rating to a buy […]
More Stories
Affirm (NASDAQ:AFRM) Sets New 12-Month High – Time to Buy?
Affirm Holdings, Inc. (NASDAQ:AFRM – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday ....
Life360 (NASDAQ:LIF) Sets New 52-Week High – Should You Buy?
Life360, Inc. (NASDAQ:LIF – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The...
Bank of Georgia Group (OTCMKTS:BDGSF) Hits New 1-Year High – Still a Buy?
Bank of Georgia Group PLC (OTCMKTS:BDGSF – Get Free Report)’s stock price reached a new 52-week high on Tuesday ....
Trump Media & Technology Group Corp. (NASDAQ:DJT) CFO Phillip Juhan Sells 320,000 Shares
Trump Media & Technology Group Corp. (NASDAQ:DJT – Get Free Report) CFO Phillip Juhan sold 320,000 shares of the business’s...
Arcellx, Inc. (NASDAQ:ACLX) Director Sells $3,516,078.82 in Stock
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) Director Kavita Patel sold 33,763 shares of the business’s stock in a transaction...
eGain (NASDAQ:EGAN) Updates Q2 2025 Earnings Guidance
eGain (NASDAQ:EGAN – Get Free Report) updated its second quarter 2025 earnings guidance on Tuesday. The company provided earnings per...